Physician profile
Thomas J Steffe
NPI 1962407221
$1,453.97
in general payments reported to CMS, 2019-2025
8 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.86 · 2021: $14.51 · 2022: $54.01 · 2023: $39.95 · 2024: $1,061 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,000 · Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $999.92 |
| Food and Beverage | $370.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $999.92 | 2024 | Acell |
| Smith+Nephew, INC. | $242.74 | 2021-2025 | Collagenase Santyl, Renasys Go V2 Home, Pico 7 |
| Organogenesis INC. | $77.39 | 2022-2025 | Puraply Wound Matrix |
| Lifenet Health | $66.73 | 2025 | Theragenesis Wound Matrix |
| Solventum Corporation | $21.33 | 2025 | Activ.A.C. |
| Takeda Pharmaceuticals U.S.A., INC. | $18.26 | 2025 | Gattex |
| Davol INC. | $14.86 | 2020 | |
| Cashflow Solutions, LLC | $12.74 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Steffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.